About
The Syndicate
The Syndicate of the Pharmaceutical Industries in Lebanon was founded in 2016. It comprises all the pharmaceutical manufacturers granted an authorization for exploitation of pharmaceutical plant according to the international good manufacturing practices by the Lebanese Ministry of Public Health.
Our Mission
Protection, promotion and enhancement of the profession, safeguarding of its interests, representation of the pharmaceutical manufacturing business before all public authorities and contribution to its advancement at all legal, regulatory, economic, industrial, commercial and social levels.
To help build a relation of collaboration and of cooperation between the Syndicate and any other authority dealing with pharmaceutical business.
To launch and sponsor awareness-raising and advertising campaigns to promote the pharmaceutical manufacturing in Lebanon and abroad.
SPIL in Numbers
Years Experience
Members
Products
Our Code of Ethics
Years Experience
President's Message
Dear Lebanese Citizens,
Dear Partners in Government, Healthcare, and Industry,
I address you as a proud representative of the Lebanese pharmaceutical sector, a sector that supported the country through its most difficult moments and carried responsibilities far beyond its size. I honor its journey and extend my gratitude to every member who acted with conviction and resilience.
For decades, this sector has been a backbone of the national health system. During the collapse of borders, supply chains and confidence, Lebanese pharmaceutical manufacturers did not stop.
We produced.
We supplied.
We protected access to medicines.
We safeguarded jobs.
We adapted quickly, expanded capacities, upgraded systems and aligned with international quality frameworks, while preserving our core mission: ensuring that medicines manufactured in Lebanon remain affordable, accessible and trusted.
Today, local pharmaceutical manufacturing stands as:
- A pillar of the economy, reducing import dependency and preserving foreign currency
- A pillar of health, ensuring continuity of care even in disruption
- A pillar of stability, sustaining more than 7,000 families and providing high-skilled career paths
- A pillar of innovation, investing in technology, quality systems and global collaborations
Countries that have secured their place in the future share one reality. They rely on a strong national pharmaceutical industry, and Lebanon is no exception.
Lebanon will remain sustainable as long as its pharmaceutical sector is protected, maintained and supported. And for that, Lebanon urgently needs a modern pharmaceutical policy that recognizes the strategic value of local production and places health security at the center of national priorities.
From our side, the Syndicate reaffirms its commitment to:
- Advocate for regulations that reward quality and affordability
- Strengthen partnerships with public authorities, healthcare
professionals and international institutions - Expand Lebanon’s presence in regional and global markets
- Preserve and elevate the standards that define our industry
- Protect our human capital and create opportunities for our youth
These commitments are not promises for tomorrow. They are the foundation of the work we are carrying forward today as we strengthen the industry, support our partners and serve the Lebanese people.
To every team member, every health professional who trusts our medicines, every institution that supports our mission and every Lebanese citizen who chooses local production, we extend our deepest respect.
The Lebanese pharmaceutical industry is rising, rebuilding and shaping a future where Lebanon stands strong, independent and forward-looking.
Together, let us build a healthier and stronger Lebanon that relies on its own resources, its own talents and its own industry.
With ambition, determination and profound commitment,
Dr. Carol Abi Karam
President
Syndicate of Pharmaceutical Industries in Lebanon
